https://daurisolineinhibitor.c....om/changeover-trajec
Cefditoren potentially plays a part in the transition from intravenous to oral antibiotic therapy for patients with acute pyelonephritis and lower respiratory tract infections. The reduction of adverse effects and hospital costs is a significant priority. Ultimately, cefditoren, purportedly through its interaction with enterococcal penicillin-binding proteins (PBPs), possibly in conjunction with other beta-lactams, could potential
Like
Comment
Share
